Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Early research (Phase 1)Active Not RecruitingNCT04483778What this trial is testingB7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsWho this might be right forPediatric Solid TumorGerm Cell TumorRetinoblastoma+14 more Seattle Children's Hospital 68
Not applicableStudy completedNCT02499458What this trial is testingProspective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal CancerWho this might be right forClear Cell Renal CancerCirculating Tumor CellsCirculating Endothelial Cells+2 more London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 44
Early research (Phase 1)Study completedNCT02035358What this trial is testingImmunotherapy Study for Metastatic Renal Cell CancerWho this might be right forMetastatic Renal Cell CarcinomaMetastatic Clear-cell Renal CancerRecurrent Renal Cell Carcinoma+2 more NewLink Genetics Corporation 18
Testing effectiveness (Phase 2)Looking for participantsNCT07023432What this trial is testingBelzutifan's Role in Active Surveillance Versus Treatment for Indolentmetastatic Clear Cell Renal Ccell Carcinoma (BRAVE-RCC)Who this might be right forActive SurveillanceClear Cell Renal Cell Carcinoma M.D. Anderson Cancer Center 78
Not applicableActive Not RecruitingNCT01582204What this trial is testingEvaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell CarcinomaWho this might be right forRenal Cancer Memorial Sloan Kettering Cancer Center 17
Very early researchStudy completedNCT05728515What this trial is testingA Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Peking Union Medical College Hospital 3
Testing effectiveness (Phase 2)Study completedNCT03015740What this trial is testingSitravatinib and Nivolumab in Treating Patients With Advanced or Metastatic Kidney CancerWho this might be right forClear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more M.D. Anderson Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT00021021What this trial is testingRPI.4610 in Treating Patients With Metastatic Kidney CancerWho this might be right forKidney Cancer Ribozyome
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07776717What this trial is testingTACTIC-RCC: Toripalimab Plus Axitinib Induction With Selective Deferred Cytoreductive Nephrectomy in TLS-Positive Advanced Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell CarcinomaAdvanced Clear Cell Renal Cell Carcinoma Fudan University 30
Testing effectiveness (Phase 2)Ended earlyNCT02581384What this trial is testingStereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms TumorsWho this might be right forEwing SarcomaRhabdomyosarcomaWilms Tumor+8 more Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT02781506What this trial is testingNivolumab and Stereotactic Ablative Radiation Therapy (SAbR) for Metastatic Clear Cell Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma University of Texas Southwestern Medical Center 7
Not applicableUnknownNCT02022787What this trial is testingValue of Various Chemokines in the Detection and Follow up of RCCWho this might be right forClear Cell Renal Cell Carcinoma Carmel Medical Center 30
Not applicableLooking for participantsNCT05214885What this trial is testingNovel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell Carcinoma Qianfoshan Hospital 300
Testing effectiveness (Phase 2)Ended earlyNCT01372813What this trial is testingVandetanib to Treat Advanced Kidney CancerWho this might be right forAdvanced Clear Cell Renal Carcinoma National Cancer Institute (NCI) 3
Early research (Phase 1)Looking for participantsNCT07300241What this trial is testingOpen-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaWho this might be right forClear Cell Renal Cell CarcinomaRenal Cell CarcinomaRCC+6 more Neomorph, Inc 30
Not applicableStudy completedNCT04006405What this trial is testingAURORAX-0087A: GAG Scores for Surveillance of Recurrence in Leibovich Points ≥5 Non-metastatic ccRCCWho this might be right forClear Cell Renal Cell Carcinoma Elypta 280
Testing effectiveness (Phase 2)Study completedNCT01510119What this trial is testingAutophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell CarcinomaWho this might be right forMetastatic Clear Cell Renal Cell Carcinoma Abramson Cancer Center at Penn Medicine 40
Early research (Phase 1)Study completedNCT04504669What this trial is testingFirst Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursWho this might be right forClear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more AstraZeneca 60
Early research (Phase 1)Study completedNCT00056537What this trial is testingABR-217620 in Patients With Advanced Non-Small Cell Lung Cancer, Renal Clear Cell Carcinoma or Pancreatic CancerWho this might be right forNon-Small-Cell Lung CarcinomaRenal Cell CarcinomaPancreatic Cancer Active Biotech AB 44